Male sex accelerates cognitive decline in GBA1 Parkinson's disease

被引:0
|
作者
Caminiti, Silvia Paola [1 ]
Avenali, Micol [1 ,2 ]
Galli, Alice [3 ]
Malito, Rachele [2 ]
Cuconato, Giada [4 ]
Galandra, Caterina [2 ]
Calabrese, Rosaria [2 ]
Pilotto, Andrea [3 ,5 ]
Padovani, Alessandro [3 ,5 ]
Blandini, Fabio [1 ,6 ]
Perani, Daniela [7 ]
Tassorelli, Cristina [1 ,2 ]
Valente, Enza Maria [2 ,4 ]
机构
[1] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy
[2] IRCCS C Mondino Fdn, Pavia, Italy
[3] Univ Brescia, Dept Clin & Expt Sci, Neurol Unit, Brescia, Italy
[4] Univ Pavia, Dept Mol Med, Pavia, Italy
[5] ASST Spedali Civili Brescia, Dept Continu Care & Frailty, Neurol Unit, Brescia, Italy
[6] Osped Maggiore Policlin, Ca Granda Fdn, Milan, Italy
[7] IRCCS San Raffaele Sci Inst, Milan, Italy
关键词
SLEEP BEHAVIOR DISORDER; QUALITY-OF-LIFE; DEMENTIA; IMPAIRMENT; CRITERIA; BIOMARKERS; MUTATIONS; MODELS; RISK; AGE;
D O I
10.1038/s41531-025-00883-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We evaluated 128 GBA and 432 nonGBA Parkinson's disease (PD) subjects available from Parkinson's Progression Markers Initiative. Baseline clinical features and dopaminergic activity were assessed, together with clinical follow-up (6.87 +/- 3.2 years). Survival analyses assessed the independent and interactive effects of sex and GBA1 mutations on cognitive decline. At baseline, GBA-PD males showed severe motor impairment, sleep disorders and memory deficits. Despite milder motor deficit, compared to GBA-PD males, GBA-PD females showed greater dopaminergic denervation, suggesting the effect of neural reserve. In longitudinal assessment, GBA-PD males showed greater MoCA rate of change per year and greater risk of cognitive impairment than GBA-PD females and nonGBA-PD. In GBA-PD males, both late age at onset and "severe/mild" GBA variants were associated with increased risk of cognitive impairment. Male sex and GBA1 carrier status have an additive value in increasing the risk of cognitive decline in PD. The effect of sex on GBA1-related pathology warrants further examination to address future trials design and patients' selection.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?
    Kopytova, Alena E.
    Usenko, Tatiana S.
    Baydakova, Galina V.
    Nikolaev, Mikhail A.
    Senkevich, Konstantin A.
    Izyumchenko, Artem D.
    Tyurin, Alexandr A.
    Miliukhina, Irina V.
    Emelyanov, Anton K.
    Zakharova, Ekaterina Y.
    Pchelina, Sofya N.
    MOVEMENT DISORDERS, 2022, 37 (08) : 1779 - 1781
  • [22] Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease
    Vieira, Sophia R. L.
    Mezabrovschi, Roxana
    Toffoli, Marco
    Del Pozo, Sara Lucas
    Menozzi, Elisa
    Mullin, Stephen
    Yalkic, Selen
    Limbachiya, Naomi
    Koletsi, Sofia
    Loefflad, Nadine
    Lopez, Grisel J.
    Gan-Or, Ziv
    Alcalay, Roy N.
    Sidransky, Ellen
    Schapira, Anthony H. V.
    MOVEMENT DISORDERS, 2024, 39 (12) : 2144 - 2154
  • [23] Investigating the pathogenesis of GBA1-associated Parkinson's disease (PD) using GBA1 isogenic iPSC lines
    Chen, Y.
    Chen, C.
    Ma, C.
    Lichtenberg, J.
    Hertz, E.
    Jong, T.
    Sam, R.
    Li, Y.
    Vrisjen, S.
    Vangheluwe, P.
    Blauwendraat, C.
    Sidransky, E.
    MOVEMENT DISORDERS, 2024, 39 : S414 - S414
  • [24] Association of GBA genotype with motor and cognitive decline in Chinese Parkinson's disease patients
    Ren, Jingru
    Zhou, Gaiyan
    Wang, Yajie
    Zhang, Ronggui
    Guo, Zhiying
    Zhou, Hao
    Zheng, Huifen
    Sun, Yu
    Ma, Changyan
    Lu, Ming
    Liu, Weiguo
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [25] Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson's disease
    Zhou, Yangjie
    Wang, Yige
    Wan, Juan
    Zhao, Yuwen
    Pan, Hongxu
    Zeng, Qian
    Zhou, Xun
    He, Runcheng
    Zhou, Xiaoxia
    Xiang, Yaqin
    Zhou, Zhou
    Chen, Bin
    Sun, Qiying
    Xu, Qian
    Tan, Jieqiong
    Shen, Lu
    Jiang, Hong
    Yan, Xinxiang
    Li, Jinchen
    Guo, Jifeng
    Tang, Beisha
    Wu, Heng
    Liu, Zhenhua
    NPJ PARKINSONS DISEASE, 2023, 9 (01)
  • [26] Effects Of GBA1 Mutations and STN-DBS On Response Inhibition in Parkinson's Disease
    Almelegy, A.
    Gunda, S.
    Buyske, S.
    Rosenbaum, M.
    Sani, S.
    Afshari, M.
    Metman, L.
    Goetz, C.
    Hall, D.
    Mouradian, M.
    Pal, G.
    MOVEMENT DISORDERS, 2023, 38 : S743 - S744
  • [27] Parkinson's disease (PD) GENEration: A cross-sectional evaluation of cognitive complaints in Parkinson's disease (PD) patients according to GBA1 and DBS status
    Son, J.
    Galvelis, K. Ghosh
    Naito, A.
    Beck, J.
    Alcalay, R.
    Pal, G.
    MOVEMENT DISORDERS, 2024, 39 : S542 - S542
  • [28] Acute Neuropsychiatric Decline in a Parkinson's Disease Patient with a Severe GBA1 Mutation Following Bilateral GPi Deep Brain Stimulation
    Palakuzhy, Vijay G.
    Pal, Gian D.
    Afshari, Mitra
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2025,
  • [29] Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study
    Toffoli, Marco
    Chohan, Harneek
    Mullin, Stephen
    Jesuthasan, Aaron
    Yalkic, Selen
    Koletsi, Sofia
    Menozzi, Elisa
    Rahall, Soraya
    Limbachiya, Naomi
    Loefflad, Nadine
    Higgins, Abigail
    Bestwick, Jonathan
    Lucas-Del-Pozo, Sara
    Fierli, Federico
    Farbos, Audrey
    Mezabrovschi, Roxana
    Lee-Yin, Chiao
    Schrag, Anette
    Moreno-Martinez, David
    Hughes, Derralynn
    Noyce, Alastair
    Colclough, Kevin
    Jeffries, Aaron R.
    Proukakis, Christos
    Schapira, Anthony H. V.
    NEUROBIOLOGY OF DISEASE, 2023, 188
  • [30] Expanding Views of Mitochondria in Parkinson’s Disease: Focusing on PINK1 and GBA1 Mutations
    Yu Yuan
    Xizhen Ma
    Ning Song
    Junxia Xie
    Neuroscience Bulletin, 2022, 38 : 825 - 828